Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPM1B | O75688 | 3/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12762660 | 0.91 | PPM1B (0.39) | PPM1BHSD17B10ALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL13897079 | 0.88 | PPM1B (0.61) | PPM1BHSD17B10ALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL9697481 | 0.88 | PPM1B (0.61) | PPM1BHSD17B10ALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL6778458 | 0.88 | PPM1B (0.61) | PPM1BHSD17B10ALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL13480836 | 0.88 | PPM1B (0.61) | PPM1BHSD17B10ALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL1005051 | 0.88 | PPM1B (0.61) | PPM1BHSD17B10ALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL11393084 | 0.88 | PPM1B (0.61) | PPM1BHSD17B10ALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL9880145 | 0.77 | PPM1B (0.56) | PPM1BHSD17B10ALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL13002242 | 0.77 | PPM1B (0.52) | PPM1BHSD17B10ALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL819846 | 0.77 | PPM1B (0.56) | PPM1BHSD17B10ALDH1A1KDM4EL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8187623-B2 | Medical copolymers | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2012-05-29 | — | — | US | disclosed |
| US-20090324679-A1 | MEDICAL COPOLYMERS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2009-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090324679-A1 | MEDICAL COPOLYMERS | CCR9, CTR9, F9 | PPM1B 1619/4885HSD17B10 1382/4885ALDH1A1 3624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.